Market Overview

UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $87.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GILD

DateFirmActionFromTo
Feb 2016OppenheimerInitiates Coverage onOutperform
Feb 2016Leerink SwannInitiates Coverage onOutperform
Feb 2016Standpoint ResearchInitiates Coverage onBuy

View More Analyst Ratings for GILD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (GILD)

Get Benzinga's Newsletters